List of SBIR/STTR awards granted to Rx Bandz
Rx BandzName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Rx Bandz in May, 2021 for $167,468.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense. | SBIR | W911QY-21-C-0065 | Phase I | 167,468 | May 12, 2021 | |||||||
A SBIR Phase II contract was awarded to Rx Bandz in June, 2022 for $750,000.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-22-P-0661 | Phase II | 750,000 | June 30, 2022 | |||||||
A STTR Phase II contract was awarded to Rx Bandz in July, 2022 for $749,988.0 USD from the U.S. Department of Defense and United States Air Force. | STTR | FA8649-22-P-1153 | Phase II | 749,988 | July 20, 2022 | |||||||
A SBIR Phase I contract was awarded to Rx Bandz in April, 2021 for $49,434.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-21-P-1167 | Phase I | 49,434 | April 14, 2021 | |||||||
A SBIR Phase I contract was awarded to Rx Bandz in April, 2021 for $49,434.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-21-P-1166 | Phase I | 49,434 | April 14, 2021 | |||||||
A SBIR Phase I contract was awarded to Rx Bandz in March, 2020 for $49,887.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-20-P-0935 | Phase I | 49,887 | March 9, 2020 | |||||||
A STTR Phase I contract was awarded to Rx Bandz in November, 2021 for $49,999.0 USD from the U.S. Department of Defense and United States Air Force. | STTR | FA864922P0072 | Phase I | 49,999 | November 5, 2021 | |||||||
A SBIR Phase II contract was awarded to Rx Bandz in August, 2021 for $749,947.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-21-P-1557 | Phase II | 749,947 | August 6, 2021 | |||||||
A SBIR Phase II contract was awarded to Rx Bandz in September, 2023 for $1,799,613.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA3016-23-C-0060 | Phase II | 1,799,613 | September 16, 2023 | |||||||
A SBIR Phase II contract was awarded to Rx Bandz in February, 2023 for $1,249,908.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-23-P-0445 | Phase II | 1,249,908 | February 10, 2023 | |||||||
A SBIR Phase II contract was awarded to Rx Bandz in September, 2023 for $1,249,908.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-23-P-1254 | Phase II | 1,249,908 | September 29, 2023 | |||||||
A SBIR Phase I contract was awarded to Rx Bandz in November, 2022 for $74,982.0 USD from the U.S. Department of Defense and United States Air Force. | SBIR | FA8649-23-P-0216 | Phase I | 74,982 | November 3, 2022 |
